ClinicalTrials.gg
Drug

Bosentan clinical trials

Also written Tracleer, Ro 47-0203 and ACT-050088.

studies test it
85
open now
3
in phase 3
27
first study started
2001

How each study uses Bosentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bosentan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Nov 2001 · TRACLEER · NDA 021290 (FDA, Drugs@FDA)
European Union
14 May 2002 · Tracleer · EMEA/H/C/000401 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bosentan
76
Bosentan 125 mg
4
Bosentan 62.5 mg
2
actelion pharmaceuticals
2

Brand

Tracleer
30

Development codes

Ro 47-0203
5
ACT-050088
4
HGP1206
1

Studies by the year they started

85 studies that test it; most in 2011 (12)

Studies that test Bosentan, by start year
YearStudies
20011
20035
20044
20055
200611
20076
20087
20095
20106
201112
20121
20134
20141
20153
20162
20171
20182
20191
20213
20241
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
16
Phase 2
26
Phase 3
27
Phase 4
15
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 37 · Other 48

Actelion (26) · Boehringer Ingelheim (3) · Assistance Publique - Hôpitaux de Paris (3) · University Hospital, Grenoble (2) · Radboud University Medical Center (2) · Medical University of Vienna (2) · Augusta University (1) · PharmaMar (1)

Often tested with

Tested in the same studies.

Sildenafil (2) · Ambrisentan (2) · Zongertinib (1) · Nerandomilast (1) · PM 01183 (1) · Zamicastat (1) · Imatinib (1) · Eplerenone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Bosentan, phase 3 first.

Studies

Open first, then newest update. How each study uses Bosentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 85

See all 85 studies that test Bosentan →

Given beside what is tested · 6 — Bosentan is usual care or a partner of the new treatment

Codes

What other systems call Bosentan · ClinicalTrials.gg INT006693

  • MeSH (NLM) D000077300BosentanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Q326023R30BOSENTANConfirmed FDA, NLM, Wikidata
  • RxNorm 75207Confirmed FDA, Wikidata
  • Wikidata Q27114267bosentan hydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47417BosentanConfirmed FDA, Wikidata

Also registered as bosentan anhydrous (UNII XUL93R30K2 · RxNorm 1468845).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.